The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Prevent Meningitis Vaccine Market Research Report 2025

Global Prevent Meningitis Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1732276

No of Pages : 106

Ask Your Query
Synopsis
Highlights
The global Prevent Meningitis Vaccine market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Prevent Meningitis Vaccine include GSK, Pfizer, Merck, Novartis, Baxter International, Sanofi Pasteur, CSL Behring, JN International Medical Corporation and Serum Institute of India, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Prevent Meningitis Vaccine in Baby is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Meningococcal A Vaccine, which accounted for % of the global market of Prevent Meningitis Vaccine in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prevent Meningitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prevent Meningitis Vaccine.
The Prevent Meningitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Prevent Meningitis Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prevent Meningitis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GSK
Pfizer
Merck
Novartis
Baxter International
Sanofi Pasteur
CSL Behring
JN International Medical Corporation
Serum Institute of India
Bio-Med
Hualan Bio
Wyeth Pharmaceuticals, Inc
Walvax
Zhejiang Tianyuan
Beijing Tiantan Biological
China National Biotec Group
Tianjin CanSino Biotechnology
Zhifei
Product Type Insights
Global markets are presented by Prevent Meningitis Vaccine type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Prevent Meningitis Vaccine are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Prevent Meningitis Vaccine segment by Type
Meningococcal A Vaccine
Meningococcal AC Vaccine
Meningococcal B Vaccine (MenB)
Meningococcal Conjugate Vaccine (MenaCWY)
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Prevent Meningitis Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Prevent Meningitis Vaccine market.
Prevent Meningitis Vaccine segment by Application
Baby
Child
Teenager
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Prevent Meningitis Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prevent Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Prevent Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Prevent Meningitis Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prevent Meningitis Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prevent Meningitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prevent Meningitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 Prevent Meningitis Vaccine Market Overview
1.1 Product Overview and Scope of Prevent Meningitis Vaccine
1.2 Prevent Meningitis Vaccine Segment by Type
1.2.1 Global Prevent Meningitis Vaccine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Meningococcal A Vaccine
1.2.3 Meningococcal AC Vaccine
1.2.4 Meningococcal B Vaccine (MenB)
1.2.5 Meningococcal Conjugate Vaccine (MenaCWY)
1.3 Prevent Meningitis Vaccine Segment by Application
1.3.1 Global Prevent Meningitis Vaccine Sales Comparison by Application: (2022-2028)
1.3.2 Baby
1.3.3 Child
1.3.4 Teenager
1.3.5 Others
1.4 Global Prevent Meningitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Prevent Meningitis Vaccine Revenue 2017-2028
1.4.2 Global Prevent Meningitis Vaccine Sales 2017-2028
1.4.3 Prevent Meningitis Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Prevent Meningitis Vaccine Market Competition by Manufacturers
2.1 Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Prevent Meningitis Vaccine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Prevent Meningitis Vaccine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Prevent Meningitis Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Prevent Meningitis Vaccine Market Competitive Situation and Trends
2.5.1 Prevent Meningitis Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Prevent Meningitis Vaccine Players Market Share by Revenue
2.5.3 Global Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prevent Meningitis Vaccine Retrospective Market Scenario by Region
3.1 Global Prevent Meningitis Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Prevent Meningitis Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Prevent Meningitis Vaccine Market Facts & Figures by Country
3.3.1 North America Prevent Meningitis Vaccine Sales by Country
3.3.2 North America Prevent Meningitis Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Prevent Meningitis Vaccine Market Facts & Figures by Country
3.4.1 Europe Prevent Meningitis Vaccine Sales by Country
3.4.2 Europe Prevent Meningitis Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Prevent Meningitis Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Prevent Meningitis Vaccine Sales by Region
3.5.2 Asia Pacific Prevent Meningitis Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Prevent Meningitis Vaccine Market Facts & Figures by Country
3.6.1 Latin America Prevent Meningitis Vaccine Sales by Country
3.6.2 Latin America Prevent Meningitis Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Prevent Meningitis Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Prevent Meningitis Vaccine Sales by Country
3.7.2 Middle East and Africa Prevent Meningitis Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Prevent Meningitis Vaccine Historic Market Analysis by Type
4.1 Global Prevent Meningitis Vaccine Sales Market Share by Type (2017-2022)
4.2 Global Prevent Meningitis Vaccine Revenue Market Share by Type (2017-2022)
4.3 Global Prevent Meningitis Vaccine Price by Type (2017-2022)
5 Global Prevent Meningitis Vaccine Historic Market Analysis by Application
5.1 Global Prevent Meningitis Vaccine Sales Market Share by Application (2017-2022)
5.2 Global Prevent Meningitis Vaccine Revenue Market Share by Application (2017-2022)
5.3 Global Prevent Meningitis Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Merck Prevent Meningitis Vaccine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Prevent Meningitis Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Baxter International
6.5.1 Baxter International Corporation Information
6.5.2 Baxter International Description and Business Overview
6.5.3 Baxter International Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
6.5.5 Baxter International Recent Developments/Updates
6.6 Sanofi Pasteur
6.6.1 Sanofi Pasteur Corporation Information
6.6.2 Sanofi Pasteur Description and Business Overview
6.6.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
6.6.5 Sanofi Pasteur Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 JN International Medical Corporation
6.8.1 JN International Medical Corporation Corporation Information
6.8.2 JN International Medical Corporation Description and Business Overview
6.8.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
6.8.5 JN International Medical Corporation Recent Developments/Updates
6.9 Serum Institute of India
6.9.1 Serum Institute of India Corporation Information
6.9.2 Serum Institute of India Description and Business Overview
6.9.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
6.9.5 Serum Institute of India Recent Developments/Updates
6.10 Bio-Med
6.10.1 Bio-Med Corporation Information
6.10.2 Bio-Med Description and Business Overview
6.10.3 Bio-Med Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
6.10.5 Bio-Med Recent Developments/Updates
6.11 Hualan Bio
6.11.1 Hualan Bio Corporation Information
6.11.2 Hualan Bio Prevent Meningitis Vaccine Description and Business Overview
6.11.3 Hualan Bio Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
6.11.5 Hualan Bio Recent Developments/Updates
6.12 Wyeth Pharmaceuticals, Inc
6.12.1 Wyeth Pharmaceuticals, Inc Corporation Information
6.12.2 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Description and Business Overview
6.12.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
6.12.5 Wyeth Pharmaceuticals, Inc Recent Developments/Updates
6.13 Walvax
6.13.1 Walvax Corporation Information
6.13.2 Walvax Prevent Meningitis Vaccine Description and Business Overview
6.13.3 Walvax Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Walvax Prevent Meningitis Vaccine Product Portfolio
6.13.5 Walvax Recent Developments/Updates
6.14 Zhejiang Tianyuan
6.14.1 Zhejiang Tianyuan Corporation Information
6.14.2 Zhejiang Tianyuan Prevent Meningitis Vaccine Description and Business Overview
6.14.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
6.14.5 Zhejiang Tianyuan Recent Developments/Updates
6.15 Beijing Tiantan Biological
6.15.1 Beijing Tiantan Biological Corporation Information
6.15.2 Beijing Tiantan Biological Prevent Meningitis Vaccine Description and Business Overview
6.15.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
6.15.5 Beijing Tiantan Biological Recent Developments/Updates
6.16 China National Biotec Group
6.16.1 China National Biotec Group Corporation Information
6.16.2 China National Biotec Group Prevent Meningitis Vaccine Description and Business Overview
6.16.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.16.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
6.16.5 China National Biotec Group Recent Developments/Updates
6.17 Tianjin CanSino Biotechnology
6.17.1 Tianjin CanSino Biotechnology Corporation Information
6.17.2 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Description and Business Overview
6.17.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
6.17.5 Tianjin CanSino Biotechnology Recent Developments/Updates
6.18 Zhifei
6.18.1 Zhifei Corporation Information
6.18.2 Zhifei Prevent Meningitis Vaccine Description and Business Overview
6.18.3 Zhifei Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
6.18.5 Zhifei Recent Developments/Updates
7 Prevent Meningitis Vaccine Manufacturing Cost Analysis
7.1 Prevent Meningitis Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Prevent Meningitis Vaccine
7.4 Prevent Meningitis Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Prevent Meningitis Vaccine Distributors List
8.3 Prevent Meningitis Vaccine Customers
9 Prevent Meningitis Vaccine Market Dynamics
9.1 Prevent Meningitis Vaccine Industry Trends
9.2 Prevent Meningitis Vaccine Market Drivers
9.3 Prevent Meningitis Vaccine Market Challenges
9.4 Prevent Meningitis Vaccine Market Restraints
10 Global Market Forecast
10.1 Prevent Meningitis Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Prevent Meningitis Vaccine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Prevent Meningitis Vaccine by Type (2023-2028)
10.2 Prevent Meningitis Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Prevent Meningitis Vaccine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Prevent Meningitis Vaccine by Application (2023-2028)
10.3 Prevent Meningitis Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Prevent Meningitis Vaccine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Prevent Meningitis Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Prevent Meningitis Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Prevent Meningitis Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Prevent Meningitis Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Prevent Meningitis Vaccine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Prevent Meningitis Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Prevent Meningitis Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Prevent Meningitis Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Prevent Meningitis Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Prevent Meningitis Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers Prevent Meningitis Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Prevent Meningitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prevent Meningitis Vaccine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Prevent Meningitis Vaccine Sales by Region (2017-2022) & (K Units)
Table 16. Global Prevent Meningitis Vaccine Sales Market Share by Region (2017-2022)
Table 17. Global Prevent Meningitis Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2017-2022)
Table 19. North America Prevent Meningitis Vaccine Sales by Country (2017-2022) & (K Units)
Table 20. North America Prevent Meningitis Vaccine Sales Market Share by Country (2017-2022)
Table 21. North America Prevent Meningitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Prevent Meningitis Vaccine Revenue Market Share by Country (2017-2022)
Table 23. Europe Prevent Meningitis Vaccine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Prevent Meningitis Vaccine Sales Market Share by Country (2017-2022)
Table 25. Europe Prevent Meningitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Prevent Meningitis Vaccine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Prevent Meningitis Vaccine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Prevent Meningitis Vaccine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Prevent Meningitis Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Prevent Meningitis Vaccine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Prevent Meningitis Vaccine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Prevent Meningitis Vaccine Sales Market Share by Country (2017-2022)
Table 33. Latin America Prevent Meningitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Prevent Meningitis Vaccine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Prevent Meningitis Vaccine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Prevent Meningitis Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Prevent Meningitis Vaccine Revenue Market Share by Country (2017-2022)
Table 39. Global Prevent Meningitis Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Prevent Meningitis Vaccine Sales Market Share by Type (2017-2022)
Table 41. Global Prevent Meningitis Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Prevent Meningitis Vaccine Revenue Share by Type (2017-2022)
Table 43. Global Prevent Meningitis Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Prevent Meningitis Vaccine Sales (K Units) by Application (2017-2022)
Table 45. Global Prevent Meningitis Vaccine Sales Market Share by Application (2017-2022)
Table 46. Global Prevent Meningitis Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Prevent Meningitis Vaccine Revenue Share by Application (2017-2022)
Table 48. Global Prevent Meningitis Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 49. GSK Corporation Information
Table 50. GSK Description and Business Overview
Table 51. GSK Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. GSK Prevent Meningitis Vaccine Product
Table 53. GSK Recent Developments/Updates
Table 54. Pfizer Corporation Information
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Pfizer Prevent Meningitis Vaccine Product
Table 58. Pfizer Recent Developments/Updates
Table 59. Merck Corporation Information
Table 60. Merck Description and Business Overview
Table 61. Merck Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Merck Prevent Meningitis Vaccine Product
Table 63. Merck Recent Developments/Updates
Table 64. Novartis Corporation Information
Table 65. Novartis Description and Business Overview
Table 66. Novartis Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Novartis Prevent Meningitis Vaccine Product
Table 68. Novartis Recent Developments/Updates
Table 69. Baxter International Corporation Information
Table 70. Baxter International Description and Business Overview
Table 71. Baxter International Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Baxter International Prevent Meningitis Vaccine Product
Table 73. Baxter International Recent Developments/Updates
Table 74. Sanofi Pasteur Corporation Information
Table 75. Sanofi Pasteur Description and Business Overview
Table 76. Sanofi Pasteur Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Sanofi Pasteur Prevent Meningitis Vaccine Product
Table 78. Sanofi Pasteur Recent Developments/Updates
Table 79. CSL Behring Corporation Information
Table 80. CSL Behring Description and Business Overview
Table 81. CSL Behring Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. CSL Behring Prevent Meningitis Vaccine Product
Table 83. CSL Behring Recent Developments/Updates
Table 84. JN International Medical Corporation Corporation Information
Table 85. JN International Medical Corporation Description and Business Overview
Table 86. JN International Medical Corporation Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. JN International Medical Corporation Prevent Meningitis Vaccine Product
Table 88. JN International Medical Corporation Recent Developments/Updates
Table 89. Serum Institute of India Corporation Information
Table 90. Serum Institute of India Description and Business Overview
Table 91. Serum Institute of India Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Serum Institute of India Prevent Meningitis Vaccine Product
Table 93. Serum Institute of India Recent Developments/Updates
Table 94. Bio-Med Corporation Information
Table 95. Bio-Med Description and Business Overview
Table 96. Bio-Med Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Bio-Med Prevent Meningitis Vaccine Product
Table 98. Bio-Med Recent Developments/Updates
Table 99. Hualan Bio Corporation Information
Table 100. Hualan Bio Description and Business Overview
Table 101. Hualan Bio Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Hualan Bio Prevent Meningitis Vaccine Product
Table 103. Hualan Bio Recent Developments/Updates
Table 104. Wyeth Pharmaceuticals, Inc Corporation Information
Table 105. Wyeth Pharmaceuticals, Inc Description and Business Overview
Table 106. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product
Table 108. Wyeth Pharmaceuticals, Inc Recent Developments/Updates
Table 109. Walvax Corporation Information
Table 110. Walvax Description and Business Overview
Table 111. Walvax Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Walvax Prevent Meningitis Vaccine Product
Table 113. Walvax Recent Developments/Updates
Table 114. Zhejiang Tianyuan Corporation Information
Table 115. Zhejiang Tianyuan Description and Business Overview
Table 116. Zhejiang Tianyuan Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Zhejiang Tianyuan Prevent Meningitis Vaccine Product
Table 118. Zhejiang Tianyuan Recent Developments/Updates
Table 119. Beijing Tiantan Biological Corporation Information
Table 120. Beijing Tiantan Biological Description and Business Overview
Table 121. Beijing Tiantan Biological Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Beijing Tiantan Biological Prevent Meningitis Vaccine Product
Table 123. Beijing Tiantan Biological Recent Developments/Updates
Table 124. China National Biotec Group Corporation Information
Table 125. China National Biotec Group Description and Business Overview
Table 126. China National Biotec Group Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. China National Biotec Group Prevent Meningitis Vaccine Product
Table 128. China National Biotec Group Recent Developments/Updates
Table 129. Tianjin CanSino Biotechnology Corporation Information
Table 130. Tianjin CanSino Biotechnology Description and Business Overview
Table 131. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product
Table 133. Tianjin CanSino Biotechnology Recent Developments/Updates
Table 134. Zhifei Corporation Information
Table 135. Zhifei Description and Business Overview
Table 136. Zhifei Prevent Meningitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Zhifei Prevent Meningitis Vaccine Product
Table 138. Zhifei Recent Developments/Updates
Table 139. Production Base and Market Concentration Rate of Raw Material
Table 140. Key Suppliers of Raw Materials
Table 141. Prevent Meningitis Vaccine Distributors List
Table 142. Prevent Meningitis Vaccine Customers List
Table 143. Prevent Meningitis Vaccine Market Trends
Table 144. Prevent Meningitis Vaccine Market Drivers
Table 145. Prevent Meningitis Vaccine Market Challenges
Table 146. Prevent Meningitis Vaccine Market Restraints
Table 147. Global Prevent Meningitis Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 148. Global Prevent Meningitis Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 149. Global Prevent Meningitis Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 150. Global Prevent Meningitis Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 151. Global Prevent Meningitis Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 152. Global Prevent Meningitis Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 153. Global Prevent Meningitis Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 154. Global Prevent Meningitis Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 155. Global Prevent Meningitis Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 156. Global Prevent Meningitis Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 157. Global Prevent Meningitis Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 158. Global Prevent Meningitis Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prevent Meningitis Vaccine
Figure 2. Global Prevent Meningitis Vaccine Market Share by Type in 2021 & 2028
Figure 3. Meningococcal A Vaccine Product Picture
Figure 4. Meningococcal AC Vaccine Product Picture
Figure 5. Meningococcal B Vaccine (MenB) Product Picture
Figure 6. Meningococcal Conjugate Vaccine (MenaCWY) Product Picture
Figure 7. Global Prevent Meningitis Vaccine Market Share by Application in 2021 & 2028
Figure 8. Baby
Figure 9. Child
Figure 10. Teenager
Figure 11. Others
Figure 12. Global Prevent Meningitis Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Prevent Meningitis Vaccine Market Size (2017-2028) & (US$ Million)
Figure 14. Global Prevent Meningitis Vaccine Sales (2017-2028) & (K Units)
Figure 15. Prevent Meningitis Vaccine Sales Share by Manufacturers in 2021
Figure 16. Global Prevent Meningitis Vaccine Revenue Share by Manufacturers in 2021
Figure 17. The Global 5 and 10 Largest Prevent Meningitis Vaccine Players: Market Share by Revenue in 2021
Figure 18. Prevent Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Prevent Meningitis Vaccine Sales Market Share by Region (2017-2022)
Figure 20. Global Prevent Meningitis Vaccine Sales Market Share by Region in 2021
Figure 21. Global Prevent Meningitis Vaccine Revenue Market Share by Region (2017-2022)
Figure 22. Global Prevent Meningitis Vaccine Revenue Market Share by Region in 2021
Figure 23. United States Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Canada Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Germany Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. France Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. U.K. Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Italy Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Russia Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. China Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Japan Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. South Korea Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. India Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Australia Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. China Taiwan Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Indonesia Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Thailand Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Malaysia Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Prevent Meningitis Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Prevent Meningitis Vaccine by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Prevent Meningitis Vaccine
Figure 47. Manufacturing Process Analysis of Prevent Meningitis Vaccine
Figure 48. Prevent Meningitis Vaccine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock